UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Darden Restaurants
DRI
$23.3B
| $67.8M | 0.02% |
621,918
+6,397
| +1% | +$726K |
|
602
KLA
KLAC
$239B
| $67.6M | 0.02% |
3,793,890
+61,580
| +2% | +$1.03M |
|
603
AutoZone
AZO
$49.2B
| $67.6M | 0.02% |
56,737
+5,784
| +11% | +$6.68M |
|
604
State Street
STT
$50.6B
| $67.6M | 0.02% |
854,290
+156,029
| +22% | +$11M |
|
|
BERY
605
DELISTED
Berry Global Group, Inc.
BERY
| $67.4M | 0.02% |
1,545,655
-93,177
| -6% | -$3.69M |
|
606
First Trust Technology AlphaDEX Fund
FXL
$2.53B
| $67.2M | 0.02% |
926,567
+90
| +0% | +$6.17K |
|
607
Aecom
ACM
$9.3B
| $66.7M | 0.02% |
1,546,168
+757,942
| +96% | +$31.4M |
|
608
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.89B
| $66.6M | 0.02% |
1,567,249
+538
| +0% | +$22.1K |
|
609
GSK
GSK
$104B
| $66.5M | 0.02% |
1,132,002
+5,440
| +0.5% | +$303K |
|
610
Bath & Body Works
BBWI
$4.06B
| $66.5M | 0.02% |
4,538,802
-372,954
| -8% | -$5.38M |
|
611
PUT
IBM
IBM
$211B
| $66.5M | 0.02% |
518,711
+315,709
| +156% | +$41M |
|
612
PUT
SPDR Gold Trust
GLD
$131B
| $66.4M | 0.02% |
465,000
-1,452,700
| -76% | -$203M |
|
613
PUT
CVS Health
CVS
$133B
| $66.3M | 0.02% |
891,900
+75,500
| +9% | +$5.3M |
|
|
PPL
614
PPL Corp
PPL
$26.5B
| $66.2M | 0.02% |
1,845,826
+773,659
| +72% | +$25.9M |
|
615
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $66.1M | 0.02% |
1,340,847
+88,972
| +7% | +$4.38M |
|
616
WisdomTree US SmallCap Dividend Fund
DES
$2.18B
| $66.1M | 0.02% |
2,303,119
-24,064
| -1% | -$671K |
|
617
Capri Holdings
CPRI
$1.83B
| $65.8M | 0.02% |
1,725,838
-563,580
| -25% | -$19.5M |
|
618
Vertex Pharmaceuticals
VRTX
$121B
| $65.8M | 0.02% |
300,623
-27,111
| -8% | -$5.49M |
|
|
CY
619
DELISTED
Cypress Semiconductor
CY
| $65.7M | 0.02% |
2,818,006
-821,717
| -23% | -$19.2M |
|
620
CALL
Advanced Micro Devices
AMD
$776B
| $65.7M | 0.02% |
1,433,211
-549,138
| -28% | -$20.2M |
|
621
Cintas
CTAS
$81.9B
| $65M | 0.02% |
966,896
+264,640
| +38% | +$17.4M |
|
622
Lennox International
LII
$14.4B
| $64.9M | 0.02% |
265,910
-972
| -0.4% | -$241K |
|
623
Yum China
YUMC
$16.5B
| $64.8M | 0.02% |
1,349,276
-308,795
| -19% | -$13.7M |
|
624
Calamos Strategic Total Return Fund
CSQ
$3.23B
| $64.6M | 0.02% |
4,752,972
-69,656
| -1% | -$913K |
|
625
Toronto Dominion Bank
TD
$198B
| $64.3M | 0.02% |
1,145,504
-291,778
| -20% | -$16.5M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.